Peers Perspectives

Risk Factors Causing Complications Due to COVID-19

Lack of Herd Immunity to COVID-19

Effect of Viral Mutations on the Spread and Severity of COVID-19

Vaccine Development to Protect Against Coronavirus

Cardiac Injury and Mortality

Complication Risk in Patients With COVID-19 & Thrombosis

Anticoagulants and COVID-19 Complications

Inpatient Services: COVID-19 and DOACs Management

Underlying Respiratory Comorbidities and COVID-19

Stratifying Patients as High-Risk With COVID-19

DVT/VTE Prophylaxis Guidelines

Venous Thromboembolism Postdischarge Risk

The Future of COVID-19 and Thromboprophylaxis Treatment

Causes of Drug Shortages in the United States

Navigating Through Drug Shortages in the Pharmacy

Addressing the Heparin Drug Shortage

Defining Medically Ill Patients for VTE Prophylaxis

Comparison of DOACs Available for VTE Prophylaxis

Implications for Treating With a DOAC for VTE Prophylaxis

Selecting & Utilizing a DOAC for VTE Prophylaxis

Addressing Drug Shortages in the United States

The Current Applications of and Opportunities for AI in Healthcare

Balancing FDA Regulation With Technology Innovation

The Implementation Hurdles Associated With Adoption of AI and Robotics

The Acquisition of Data and the Issue of Privacy

Facial Recognition and the Future of AI in Medicine

Fighting Bias in Data and AI

Telemedicine and Technology Infrastructure

Future Opportunities for AI Integration

The Definition of AI and Innovation Opportunities in Medicine

Malnutrition: A Public Health Challenge

Assessment of Nutritional Status

Malnutrition: A Challenge in Elderly Patients

Recommendations for Healthy Eating

Access to Healthy Foods to Maintain a Healthy Diet

Nutrition and Overall Health Status in Elderly Patients

Self-Discipline and Diet

Strategies to Ensure Healthy Eating in Elderly Patients

Advice for Changing Dietary Eating Habits

A Healthy Day's Diet

Polypharmacy and Nutrition in Elderly Patients

Challenges in Identifying and Treating Schizophrenia

Considering Patient Nonadherence to Schizophrenia Medication

Schizophrenia: The Risk and Impact of Recurrence

Benefit of Long-Acting Injectables in Treating Schizophrenia

Schizophrenia: Nuance in Switching to Long-Acting Injectables

Addressing Hesitation in Switching to LAIs in Schizophrenia

LAIs in Schizophrenia: Shortcomings in Available Guidelines

Earlier Use of Long-Acting Injectables in Schizophrenia

Practical Advice on Long-Acting Injectables in Schizophrenia

Questions About the Future Management of Schizophrenia